Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. JPM
2. BAC
3. SPY
4. WFC
5. ERAS
6. IBM
7. SPRO
8. TREX
9. AAPL
10. ORCL

Go back to Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 56.45 --0 (-0%)
Previous Close $56.45    52 Week High $3.48 
Open $56.45    52 Week Low $0.80 
Day High $56.45    P/E N/A 
Day Low $56.45    EPS $-1.54 
Volume 326       

(NASDAQ: ZYME) Delayed: 24.94 --0 (-0%)
Previous Close $24.94    52 Week High $ 
Open $24.94    52 Week Low $ 
Day High $24.94    P/E N/A 
Day Low $24.94    EPS $ 
Volume 19,400